22 May 2013
Keywords: SkyePharma, Abbott Labs, Flutiform, NDA, FDA, Licensing
Article | 08 February 2010
The UK’s drug formulation specialist SkyePharma says that the US New Drug Application for its investigation asthma drug Flutiform ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 February 2010
21 May 2013
© 2013 thepharmaletter.com